web analytics
November 30, 2015 / 18 Kislev, 5776
At a Glance
Sponsored Post

Israeli Company Wins FDA Approval For Bone Cancer Treatment

JewishPress Logo

Israeli med-tech company InSightec Image Guided Treatment has announced that it has been approved for US Food and Drug Administration (FDA) premarketing of its ExAblate targeted focused ultrasound treatment for the removal of bone tumors.

According to Globes online business magazine, the initial approval is for patients who cannot or will not undergo radiation therapy.

According to InSightec, 30% of bone cancer patients cannot undergo radiation treatment.

InSightec is controlled by Elbit Medical Technologies.

About the Author: Malkah Fleisher is a graduate of Cardozo Law School in New York City. She is an editor/staff writer at JewishPress.com and co-hosts a weekly Israeli FM radio show. Malkah lives with her husband and two children on the Mount of Olives in Jerusalem.

If you don't see your comment after publishing it, refresh the page.

Our comments section is intended for meaningful responses and debates in a civilized manner. We ask that you respect the fact that we are a religious Jewish website and avoid inappropriate language at all cost.

If you promote any foreign religions, gods or messiahs, lies about Israel, anti-Semitism, or advocate violence (except against terrorists), your permission to comment may be revoked.

No Responses to “Israeli Company Wins FDA Approval For Bone Cancer Treatment”

Comments are closed.

Current Top Story
Yinon Magal of the Bayit Yehudi party.
Bayit Yehudi’s Yinon Magal Announces Resignation from Knesset

Printed from: http://www.jewishpress.com/news/israeli-company-wins-fda-approval-for-bone-cancer-treatment/2012/10/22/

Scan this QR code to visit this page online: